Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 17, 2021

View Archived Issues

KRAS just wants to help: Pancreatic KRAS mutations may be protection gone bad

CNGA1 behind retinal degeneration, murine model shows

Guanylate cyclase C agonist IW-3300 shows promise for treating visceral pain

Mitokinin discloses PINK1 activators

Bahcesehir Universitesi presents Hdm2 inhibitors

Achillion Pharmaceuticals identifies new complement factor D inhibitors

UCL Business describes new CRP inhibitors

Nanjing Sanhome Pharmaceutical divulges anti-CD47/anti-PD-L1 antibodies

Novel potent TGR5 agonist shows antidiabetic effects in TGR5(H88Y) mutant mice

VU-6028418 reverses cataleptic behavior in rat models

Endeavor BioMedicines licenses rights to ULK1/2 inhibitor for LKB1- and RAS-mutated cancers

Targeting PANX1/IL-33 axis decreases MRSA infection-induced liver damage

RARG rs2229774 genetic variant identifies cardioprotective therapy

Bantam completes seed funding to advance BTM-3566 toward the clinic

Tarveda and SciClone enter license agreement for preclinical PI3K miniature drug conjugates

Targeting RON short form suppresses breast cancer metastasis through subverted immunosuppression

Clarus licenses rights to McGill technology to treat conditions associated with CoQ10 deficiencies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...